{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:08:33Z","timestamp":1788448113466,"version":"build-2803163510"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100003921","name":"Department of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008721","name":"UCLH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008721","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UCL Biomedical Research Centre"},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute of Health Research Senior Investigators"},{"name":"Alzheimer\u2019s Society UK"},{"DOI":"10.13039\/100015873","name":"National Brain Appeal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015873","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The clinical effectiveness of any disease-modifying treatment for prion disease, as for other neurodegenerative disorders, will depend on early treatment before damage to neural tissue is irrevocable. Thus, there is a need to identify markers that predict disease onset in healthy at-risk individuals. Whilst imaging and neurophysiological biomarkers have shown limited use in this regard, we recently reported progressive neurophysiological changes in individuals with the inherited prion disease mutation P102L. We have also previously demonstrated a signature pattern of fronto-parietal dysfunction in mild prion disease. Here we address whether these cognitive features anticipate the onset of symptoms in a unique sample of patients with inherited prion disease. In the cross-sectional analysis, we analysed the performance of patients at three time points in the course of disease onset: prior to symptoms (n\u2009=\u200927), onset of subjective symptoms without positive clinical findings (n\u2009=\u20098) and symptomatic with positive clinical findings (n\u2009=\u200924). In the longitudinal analysis, we analysed data from 24 patients who were presymptomatic at the time of recruitment and were followed up over a period of up to 17 years, of whom 16 remained healthy and eight converted to become symptomatic. In the cross-sectional analysis, the key finding was that, relative to a group of 25 healthy non-gene carrier controls, patients with subjective symptoms but without positive clinical findings were impaired on a smaller but similar set of tests (Trail Making Test part A, Stroop test, Performance IQ, gesture repetition, figure recall) to those previously found to be impaired in mild prion disease. In the longitudinal analysis, Trail Making Test parts A and B, Stroop test and Performance IQ scores significantly discriminated between patients who remained presymptomatic and those who converted, even before the converters reached criteria for formal diagnosis. Notably, performance on the Stroop test significantly discriminated between presymptomatic patients and converters before the onset of clinical symptoms [area under the curve = 0.83 (95% confidence interval, 0.62\u20131.00), P\u2009=\u20090.009]. Thus, we report here, for the first time, neuropsychological abnormalities in healthy patients prior to either symptom onset or clinical diagnosis of inherited prion disease. This constitutes an important component of an evolving profile of clinical and biomarker abnormalities in this crucial group for preventive medicine.<\/jats:p>","DOI":"10.1093\/brain\/awaa409","type":"journal-article","created":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T15:14:59Z","timestamp":1604934899000},"page":"989-998","source":"Crossref","is-referenced-by-count":3,"title":["Cognitive decline heralds onset of symptomatic inherited prion disease"],"prefix":"10.1093","volume":"144","author":[{"given":"Joseph","family":"Mole","sequence":"first","affiliation":[{"name":"Department of Neuropsychology, NHNN, University College London Hospitals NHS Foundation Trust, London, UK"},{"name":"Queen Square Institute of Neurology, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Mead","sequence":"additional","affiliation":[{"name":"National Prion Clinic, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust (UCLH), London, UK"},{"name":"MRC Prion Unit at UCL, UCL Institute of Prion Diseases, London, W1W 7FF, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rudge","sequence":"additional","affiliation":[{"name":"National Prion Clinic, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust (UCLH), London, UK"},{"name":"MRC Prion Unit at UCL, UCL Institute of Prion Diseases, London, W1W 7FF, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2892-1402","authenticated-orcid":false,"given":"Akin","family":"Nihat","sequence":"additional","affiliation":[{"name":"National Prion Clinic, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust (UCLH), London, UK"},{"name":"MRC Prion Unit at UCL, UCL Institute of Prion Diseases, London, W1W 7FF, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzehow","family":"Mok","sequence":"additional","affiliation":[{"name":"National Prion Clinic, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust (UCLH), London, UK"},{"name":"MRC Prion Unit at UCL, UCL Institute of Prion Diseases, London, W1W 7FF, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Collinge","sequence":"additional","affiliation":[{"name":"National Prion Clinic, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust (UCLH), London, UK"},{"name":"MRC Prion Unit at UCL, UCL Institute of Prion Diseases, London, W1W 7FF, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Caine","sequence":"additional","affiliation":[{"name":"Department of Neuropsychology, NHNN, University College London Hospitals NHS Foundation Trust, London, UK"},{"name":"National Prion Clinic, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust (UCLH), London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,4,9]]},"reference":[{"key":"2021070719462826900_awaa409-B1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1155\/1994\/659593","article-title":"Measuring dysgraphia: a graded-difficulty spelling test","volume":"7","author":"Baxter","year":"1994","journal-title":"Behav Neurol"},{"key":"2021070719462826900_awaa409-B2","author":"Bishop","year":"1989","edition":"2nd edn"},{"key":"2021070719462826900_awaa409-B3","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1176\/jnp.2008.20.4.466","article-title":"Neuropsychological deficits in Huntington's disease gene carriers and correlates of early \u201cconversion\u201d","volume":"20","author":"Brandt","year":"2008","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"2021070719462826900_awaa409-B4","doi-asserted-by":"crossref","first-page":"e0190818","DOI":"10.1371\/journal.pone.0190818","article-title":"The language disorder of prion disease is characteristic of a dynamic aphasia and is rarely an isolated clinical feature","volume":"13","author":"Caine","year":"2018","journal-title":"PLoS One"},{"key":"2021070719462826900_awaa409-B5","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/acn3.195","article-title":"The cognitive profile of prion disease: a prospective clinical and imaging study","volume":"2","author":"Caine","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"key":"2021070719462826900_awaa409-B5599671","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1017\/S135561771500003X","article-title":"Limitations of the trail making test part-B in assessing frontal executive dysfunction","volume":"21","author":"Chan","year":"2015","journal-title":"J Int Neuropsychol Soc"},{"key":"2021070719462826900_awaa409-B54386287","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropsychologia.2016.09.018","article-title":"Inhibition processes are dissociable and lateralized in human prefrontal cortex","volume":"93","author":"Cipolotti","year":"2016","journal-title":"Neuropsychologia"},{"key":"2021070719462826900_awaa409-B6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1136\/jnnp.2003.030320","article-title":"The neuropsychology of variant CJD: a comparative study with inherited and sporadic forms of prion disease","volume":"76","author":"Cordery","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2021070719462826900_awaa409-B7","author":"Coughlan","year":"1986"},{"key":"2021070719462826900_awaa409-B8","first-page":"109","article-title":"Defining disease modifying therapy for Alzheimer's disease","volume":"4","author":"Cummings","year":"2017","journal-title":"J Prev Alzheimers Dis"},{"key":"2021070719462826900_awaa409-B9","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1136\/jnnp-2016-313501","article-title":"Quantitative EEG parameters correlate with the progression of human prion diseases","volume":"87","author":"Franko","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2021070719462826900_awaa409-B10","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1136\/jnnp.61.2.176","article-title":"Defective imitation of gestures in patients with damage in the left or right hemispheres","volume":"61","author":"Goldenberg","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2021070719462826900_awaa409-B11","author":"Halstead","year":"1985"},{"key":"2021070719462826900_awaa409-B12","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0010-9452(86)80020-X","article-title":"Arithmetic skills in patients with unilateral cerebral lesions","volume":"22","author":"Jackson","year":"1986","journal-title":"Cortex"},{"key":"2021070719462826900_awaa409-B13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.parkreldis.2016.02.008","article-title":"Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's Disease","volume":"25","author":"Martinez-Horta","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"2021070719462826900_awaa409-B14","author":"McKenna","year":"1980"},{"key":"2021070719462826900_awaa409-B15","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1212\/WNL.0000000000007745","article-title":"Age at onset in genetic prion disease and the design of preventive clinical trials","volume":"93","author":"Minikel","year":"2019","journal-title":"Neurology"},{"key":"2021070719462826900_awaa409-B16","author":"Nelson","year":"1982"},{"key":"2021070719462826900_awaa409-B17","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/brain\/awy358","article-title":"Early neurophysiological biomarkers and spinal cord pathology in inherited prion disease","volume":"142","author":"Rudge","year":"2019","journal-title":"Brain"},{"key":"2021070719462826900_awaa409-B18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1076\/jcen.24.2.133.998","article-title":"Psychomotor, executive, and memory function in preclinical Huntington's disease","volume":"24","author":"Snowden","year":"2002","journal-title":"J Clin Exp Neuropsychol"},{"key":"2021070719462826900_awaa409-B19","author":"Spreen","year":"1998"},{"key":"2021070719462826900_awaa409-B20","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1093\/brain\/awt048","article-title":"The Medical Research Council prion disease rating scale: a new outcome measure for prion disease therapeutic trials developed and validated using systematic observational studies","volume":"136","author":"Thompson","year":"2013","journal-title":"Brain"},{"key":"2021070719462826900_awaa409-B21","author":"Trenerry","year":"1989"},{"key":"2021070719462826900_awaa409-B22","author":"Warrington","year":"1984"},{"key":"2021070719462826900_awaa409-B23","author":"Warrington","year":"1991"},{"key":"2021070719462826900_awaa409-B24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/713755564","article-title":"Single word comprehension: a concrete and abstract word synonym test","volume":"8","author":"Warrington","year":"1998","journal-title":"Neuropsychol Rehabil"},{"key":"2021070719462826900_awaa409-B98675311","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1093\/brain\/awn202","article-title":"Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series","volume":"131","author":"Webb","year":"2008","journal-title":"Brain"},{"key":"2021070719462826900_awaa409-B25","author":"Wechsler","year":"1997"},{"key":"2021070719462826900_awaa409-B26","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneurol.2016.65","article-title":"Advanced tests for early and accurate diagnosis of Creutzfeldt-Jakob disease","volume":"12","author":"Zanusso","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"2021070719462826900_awaa409-B27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/144\/3\/989\/37036606\/awaa409.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/144\/3\/989\/37036606\/awaa409.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T17:24:24Z","timestamp":1625678664000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/144\/3\/989\/6222675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,1]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,4,9]]},"published-print":{"date-parts":[[2021,4,12]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awaa409","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.09.14.20194217","asserted-by":"object"}]},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,3,1]]},"published":{"date-parts":[[2021,3,1]]}}}